NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed...
Lemonaid Health, a San Francisco-based telehealth platform and provider, announced today $33 million in Series B funding. The new round was led...
Dive Brief: The Federal Communications Commission has only sent one provider funds to build out its telehealth infrastructure, despite approving more than...